News / Prostate

    ConcertAI’s TeraRecon Enhances its Eureka Clinical AI Platform with AI-Based Prostate Cancer Diagnostic Solutions from Lucida Medical

    by TeraRecon, on Nov 15, 2023 10:52:39 AM

    ConcertAI’s TeraRecon Enhances its Eureka Clinical AI Platform with AI-Based Prostate Cancer Diagnostic Solutions from Lucida Medical

    CAMBRIDGE, Mass., Nov. 15, 2023 -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, today announced the addition of Lucida Medical to its Eureka Clinical AI Platform ecosystem …

    Read Story

    ConcertAI's TeraRecon adds Prostate Cancer Detection/Diagnosis into Eureka Clinical AI Platform with Bot Image, Inc. Partnership

    by TeraRecon, on May 26, 2023 8:39:00 AM

    ConcertAI's TeraRecon adds Prostate Cancer Detection/Diagnosis into Eureka Clinical AI Platform with Bot Image, Inc. Partnership

    CAMBRIDGE, Mass., May 26, 2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS category leader, now provides clinicians with the state-of-the-art …

    Read Story
    Prev All Posts Next

    About TeraRecon

    TeraRecon is a leader in advanced visualization, artificial intelligence, image viewing, and post-processing.

    Learn More →

    Subscribe to Receive News Updates

    TeraRecon, Inc

    TeraRecon Headquarters
    4309 Emperor Blvd, Suite 310
    Durham, NC 27703 
    Tel: 650.372.1100
    Fax: 650.372.1101
    info@terarecon.com 

     

    All offerings are subject to availability and regulatory clearance, which may vary by country. Please verify product status with your local TeraRecon representative.

     

    Additional Resources

    Subscribe to our newsletter

    ©2024 Terarecon, Inc. All Rights Reserved.